Engineering extremely strong immune systems.

Our company scientists have successfully combined multiple immune systems, to form an extremely strong immune system. The resultant immuno-therapeutic product (AbstimX™) has been validated in mouse studies at our laboratory at the University of Toronto, to prevent both breast cancer and inflammatory bowel disease.  We are confident that AbstimX™ will also be effective for the prevention of other cancers and other inflammatory/autoimmune diseases. 

Network Immunology Inc. is a privately held biotech company that develops patented immuno-therapeutics based on immune network theory.

 

Chief Scientist Dr. Geoffrey W. Hoffmann

CSO Geoffrey W. Hoffman Explains Immune Network Theory. ..

Interview on Organ Transplantation, Harpreet Singh Show

CEO George Hoffman discusses Network Immunology's latest research breakthrough in organ transplantation. ..

Network Immunology Releases Breakthrough Data from Organ Transplantation Study

Toronto, ON: Network Immunology has received breakthrough data for its platform Co-selection Technology™ that has potential applications to transplantation, autoimmunity and other degenerati..

Corporate Updates

Captcha Image